Guidance is needed regarding potential extension of the World Health Organization recommendation for cord cleansing with chlorhexidine to babies born in facilities. Among 3223 facility-born babies from Nepal and Bangladesh, mortality was approximately halved among those allocated to the intervention clusters [10.5/1000 vs. 19.4/1000; relative risk (RR): 0.54; 95% confidence interval: 0.30-0.97]. In high-mortality settings, a single policy for home and facility births is warranted.
I
n 2013, the World Health Organization provided updated guidance for umbilical cord care, advising use of 4.0% chlorhexidine (7.1% chlorhexidine digluconate) cord cleansing for home births in settings with high neonatal mortality. 1 These updated guidelines focused on home births, because the South Asian trials that formed the basis of new recommendations were dominated by home births (>90%) [2] [3] [4] and the neonatal mortality rate (NMR) in those trials exceeded 30/1000. Two recent studies 5, 6 in substantially lower risk settings in Tanzania and Zambia (NMR <11/1000 and <15/1000, respectively) provided no evidence that the intervention would improve survival in settings where mortality was already low. In high-mortality settings, however, policymakers need further guidance on whether or not to extend their emerging chlorhexidine cleansing programs to facility births. Such guidance is critical as the proportion of facility births in many low-resource areas of South Asia and sub-Saharan Africa is increasing rapidly, without sufficient evidence that survival rates among these babies are improving. 7 In this brief report, we pool data from our 2 large, popinfiltrates began to disappear, and no progression was observed. Oral prednisolone was added at a dose of 20 mg/d at hospital day 5 and was tapered until therapy was discontinued. After finishing the intravenous acyclovir regimen, she was discharged with a prescription of oral acyclovir 800 mg every 6 h/d and oral prednisolone 15 mg/d. At the time of discharge, peripheral infiltrates began to change into a pigmentary scar (Fig. 2C) , both her floater symptoms and inflammatory signs on slit-lamp examination were improved and her bestcorrected visual acuity was maintained at 20/20. No vascular leakage was observed on follow-up fundus fluorescein angiogram at the 1-month visit ( Fig. 3A and B) . Three months after the acute episode, an attached retina with peripheral pigmentation was observed. No recurrence was observed, and all medication was stopped.
DISCUSSION
Primary infection with VZV causes chickenpox in children. After a long latent period of incubation in the sensory ganglia, VZV can reactivate when host immunity is compromised, causing herpes zoster and other neurologic diseases.
1 ARN is a well-known reactivated VZV-induced necrotizing retinitis that usually occurs in immunocompetent young adults. The clinical entity of typical ARN has been well described in previous reports. 2, 3 However, retinitis associated with chickenpox is rare, and only a few cases have been reported. The corresponding clinical course and prognosis are variable according to case reports, and differences between adults and children are not well-known due to the relative rarity of the complication. Culbertson et al 5 reported 4 elderly patients who developed a mild form of ARN after the onset of chickenpox. Kitamei et al 6 reported on a case of unilateral chickenpox chorioretinitis with retinal exudates and periphlebitis in a 21-year-old healthy man with good visual prognosis. Lee and Charles 7 reported a case of a 4-yearold patient with unusually severe retinitis culminating in total retinal detachment. Other reports also document poor visual outcome with a visual acuity less than 20/200 in children with chickenpoxassociated retinitis. 4, 8, 9 Unlike elderly patients, poor visual prognosis of pediatric patients may be possibly due to the immature immune system, delayed complaints of their ocular symptom and delay in diagnosis. Only 2 reports have described good visual outcome in pediatric cases of varicella-associated retinitis. 10, 11 We present the case of a 10-year-old female with VZV-associated retinitis after chickenpox. Compared with a typical ARN, our patient experienced a relatively mild clinical course and good visual outcome. The interval between the onset of chickenpox and that of ocular symptoms was about 3 weeks. Although the viral PCR in the anterior chamber was negative for VZV, the clinical features resembled early findings of ARN. We started intravenous acyclovir promptly, and the patient had a favorable visual outcome without complications.
ulation-based trials in Nepal and Bangladesh and summarize the impact of chlorhexidine for cord cleansing on mortality, omphalitis and cord separation time among babies born in first-level rural health facilities.
METHODS

Study Design and Data Collection
The details of the design and the results of our 2 trials have been previously published. 2, 3 Briefly, in both settings (Sarlahi District, Nepal and Sylhet District, Bangladesh), we enumerated households and women of child bearing age, identified pregnancies through routine community-based (ie, household visits) surveillance, and followed pregnant women through 28 days postpartum. Babies (facility or home births) met alive by community health workers were provided with a cord care regimen to which the geographic cluster of their home had been randomly allocated. In Nepal, a multiple-day chlorhexidine cleansing regimen (days 1, 2, 3, 4, 6, 8 and 10) was compared with soap and water cleansing or dry cord care (no cleansing). In Bangladesh, 2 separate chlorhexidine regimens-a single-day regimen (day 1) and a multipleday regimen (days 1-7) -were compared with dry cord care. In both settings, a data collection team visited all babies at home on a fixed visit schedule to collect signs of omphalitis (pus, redness and swelling), status of cord separation and vital status. Field workers were trained on signs of omphalitis (by L.C.M.) using a previously validated standard protocol and a set of training images of the cord stump and infection. 
Analysis
The primary outcome of interest was death within 28 days after birth. We also examined risk of omphalitis using 3 infection definitions [mild (pus or redness limited to cord stump), moderate (pus and redness extending to the base around the stump), severe (pus and redness >2 cm from the base)]. Time to cord separation was defined as the age of the baby at the mid-point between the first visit at which the cord was observed to have fallen and the prior visit. The definitions, risk factors for and burden of omphalitis in these settings, along with descriptions of population-based cord separation time, are available. [9] [10] [11] Here, we restrict our analysis to the subset of enrolled babies who were born in facilities; these occurred predominately in low-level public facilities (health posts/primary health centers in Nepal; Family Welfare Centers in Bangladesh), service provision sites that often struggle to provide basic but essential maternal and neonatal services, such as hygienic delivery, emergency obstetric services or implement standard infection control procedures. In the primary analysis, we combined chlorhexidine regimens regardless of frequency and compared these clusters to those where chlorhexidine was not provided; in addition, we examined chlorhexidine impact when comparing multiple-day cleansing versus dry cord care and any chlorhexidine versus dry cord care. We examined comparability of the groups by assessing a range of household, maternal and child characteristics. Comparative risk for mortality and omphalitis was estimated using binomial regression with log link functions; simple linear regression was used to compare mean time to cord separation. In all cases, standard errors were adjusted for clustered randomization, using generalized estimating equations. We did not account for multiple comparisons. Analyses were done utilizing STATA 14.2 (StataCorp LLC, College Station, TX).
RESULTS
A total of 3223 babies were born in facilities (Nepal: 1245; Bangladesh: 1978) during the study period and enrolled in the trials. Of these, 1728 (53.6%) were male, 887 (27.9%) were low birth weight (missing for 40 babies) and 424 (13.2%) were preterm (<37 weeks); the majority of babies (57.1%) were born to mothers less than 25 years of age. Within this subanalysis of facility births, the original randomization schemes achieved balance on most variables. When comparing clusters allocated to chlorhexidine cleansing regimens compared with clusters allocated to nonchlorhexidine regimens, babies were evenly distributed in terms of sex, low birth weight, preterm status, breastfeeding initiation time and provision of colostrum, hand washing of birth attendant before delivery, maternal literacy/education and caste and ethnicity (variable for Nepal only). Mothers of babies in chlorhexidine clusters were less likely to have received 2 doses of tetanus toxoid in the prior 2 years (26.9% vs. 41.8%), were slightly older (25.6 vs. 24.4 years) and less likely to report that their baby's cord was cut with a sterile instrument (29.5% vs. 39.7%).
Among babies enrolled in the trials, overall mortality within 28 days for those born in a facility was 14. severe omphalitis did not differ between the groups, but risk was uniformly low (<1% in both groups). Age at cord separation was higher among babies exposed to chlorhexidine (6.5 days) compared with nonchlorhexidine groups (5.1 days), a difference of 1.36 days (95% CI: 1.14-1.58). All estimation models were rerun including covariates that were imbalanced (maternal age, use of sterile cord cutting instrument and tetanus toxoid coverage) in addition to low birth weight and gestational age, and the results did not change (data not shown).
DISCUSSION
Our pooled analysis demonstrates that cord cleansing with chlorhexidine can reduce mortality and infection risk among facility births, with magnitudes similar to the previously published population-based estimates forming the basis of the World Health Organization's 2013 guideline update. Furthermore, the overall mean time to cord separation, which is inversely proportional to the level of bacterial exposure and colonization of the cord stump tissues, was low (5.8 days) and was increased by 1.36 days, similar to population-level increases in these sites.
Two issues should be considered when interpreting these results. First, while this analysis provides information on more than 3000 facility births, approximately half of which received chlorhexidine, the overall impact on neonatal mortality will be lower than observed here, as live born babies who died before being met (ie, died in facility or after discharge, but before being visited by study workers) were not enrolled. Unfortunately, we did not have complete individual-level information on birth location for babies not enrolled. For the subset where this is available, however, NMR was 30.3/1000, which was similar to home births in Bangladesh (35.4/1000) and Nepal (34.2/1000) during the trial period. Second, the chlorhexidine group in our primary analysis comprises 3 varying chlorhexidine regimens (single-day cleansing, daily for first 7 days or 7 cleansings over first 10 days). Thus, in this or other pooled-or meta-analyses of chlorhexidine studies, decisions regarding if and how to combine slightly varying cord care regimens are required. Here, for our primary analysis, we V ertebral osteomyelitis in children accounts for only 1%-2% of all children with osteomyelitis, and it is rarely seen in neonates. 1, 2 Osteomyelitis in children is usually caused by hematogenous seeding and occurs typically in long bones. The inflammation affects mainly the metaphyses of the femur, humerus and tibia. Short or flat bones are less frequently involved. [3] [4] [5] [6] The most frequent causative agent is Staphylococcus aureus, followed by Salmonella, Streptococcus pneumonia, Pseudomonas aeruginosa and group B Streptococcus. [3] [4] [5] 7 Neonatal cervical osteomyelitis is extremely rare, with only a few anecdotal reports having been reported to date.
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CASE
A 5-week-old female presented to our hospital with fever of 1 week duration, irritability and decreased spontaneous arm movements. One week before her admission to our center, she presented to an emergency department in a different hospital because of fever, and she was discharged home after a negative sepsis work-up. During the following week, the fever persisted, and a watery diarrhea was noted. The mother reported an uneventful pregnancy with normal prenatal care. She denied oligohydroamniosis, abnormal fetal lie, trauma during pregnancy or a difficult delivery, as well as any compared any chlorhexidine to nonchlorhexidine groups, as was previously conducted for a meta-analysis of all South Asian trials 12 ; the specific choice made here did not affect our conclusion.
That chlorhexidine cleansing interventions would work similarly among babies born in facilities in these settings should not be surprising. In these districts, as in many low-resource settings achieving remarkable gains in rate of facility delivery, the circumstances surrounding birth that might affect risk of neonatal mortality through pathogens colonizing the patent, freshly cut vessels of the cord stump, are unlikely to differ between home and facility births. The latter overwhelmingly occur in first-level facilities where reliable supplies of electricity and clean, running water are often unavailable, basic distribution of medical equipment and medicines are often disrupted, staff are commonly under-resourced or insufficiently trained, and mothers and babies are discharged within hours of delivery. 7 In such situations, extending a simple and cost-effective means to reduce infection risk and improve survival with chlorhexidine should be considered. In addition to the direct effect that use of chlorhexidine cleansing can have for facility births, overall coverage and reach of national programs to home births may be facilitated through uniform recommendations for cord care. Instead of attempting to promote different care regimens by place of delivery, a distinction that may not correlate substantively with underlying risk, a single uniform policy should be implemented. Additionally, policy makers should carefully consider the wisdom of adhering to a strict threshold (eg, 30/1000) for decision-making regarding chlorhexidine cleansing programs. While the absolute and relative efficacy of chlorhexidine cord cleansing likely diminishes as underlying risk of mortality decreases, there is little reason to believe the benefit immediately decreases to zero as NMR passes below that threshold. At the national level, where policy decisions are made, a strict quantitative threshold is also problematic in light of subnational geographic and seasonal differences in risk, and inherent uncertainty in estimates of NMR. Given the low cost and high potential for improved survival and reduced morbidity, those most proximally responsible for steering neonatal health programming should implement a single chlorhexidine cleansing policy, regardless of birth location and level of mortality, until the health system can achieve clean and hygienic conditions at all levels.
